The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[{1-(tert-Butyl)-5-(4-cyclohexylphenyl)-1H-pyrazol-3-yl}methyl]-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide ID: ALA4096567
PubChem CID: 137654122
Max Phase: Preclinical
Molecular Formula: C27H33N3O2S
Molecular Weight: 463.65
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)n1nc(CN2Cc3ccccc3S2(=O)=O)cc1-c1ccc(C2CCCCC2)cc1
Standard InChI: InChI=1S/C27H33N3O2S/c1-27(2,3)30-25(22-15-13-21(14-16-22)20-9-5-4-6-10-20)17-24(28-30)19-29-18-23-11-7-8-12-26(23)33(29,31)32/h7-8,11-17,20H,4-6,9-10,18-19H2,1-3H3
Standard InChI Key: KYSBXUISFUMGSC-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
14.6145 -9.0964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7973 -9.0964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2059 -9.8041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6281 -5.6955 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.1070 -6.3585 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6215 -7.0137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8463 -6.7569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8530 -5.9397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1472 -5.5295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4348 -5.9323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4323 -6.7495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1380 -7.1638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9241 -6.3610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8052 -8.2841 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1440 -7.7985 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4001 -7.0266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2186 -7.0266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4665 -7.8045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1819 -8.1976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8798 -7.7757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6002 -8.1691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6144 -8.9838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9162 -9.4098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2000 -9.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3405 -5.2885 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.2998 -4.9455 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0907 -9.5035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3302 -9.3770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3453 -10.1950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0573 -10.5888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7588 -10.1689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7437 -9.3509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0271 -8.9528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
4 8 1 0
9 10 1 0
10 11 2 0
11 12 1 0
7 12 2 0
8 9 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
14 18 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
18 19 1 0
14 2 1 0
13 16 1 0
5 13 1 0
4 25 2 0
4 26 2 0
2 27 1 0
28 29 1 0
28 33 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
22 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 463.65Molecular Weight (Monoisotopic): 463.2293AlogP: 6.06#Rotatable Bonds: 4Polar Surface Area: 55.20Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.91CX Basic pKa: 1.50CX LogP: 5.75CX LogD: 5.75Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.47Np Likeness Score: -0.80
References 1. Hong JR, Choi YJ, Keum G, Nam G.. (2017) Synthesis and diabetic neuropathic pain-alleviating effects of 2N-(pyrazol-3-yl)methylbenzo[d]isothiazole-1,1-dioxide derivatives., 25 (17): [PMID:28720324 ] [10.1016/j.bmc.2017.07.008 ]